• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Robert Langreth

Stay informed with Robert Langreth’s coverage and analysis.

Merck snags Chinese obesity drug in nearly $2 billion deal
Tech
Merck snags Chinese obesity drug in nearly $2 billion deal
By Robert Langreth and BloombergDecember 18, 2024
Close-up of an Ozempic pen in a greenwash style
Health
Ozempic linked to rare cases of vision loss in Harvard study
By Robert Langreth and BloombergJuly 3, 2024
Lilly wins FDA approval for new drug to slow Alzheimer’s
Health
Lilly wins FDA approval for new drug to slow Alzheimer’s
By Madison Muller, Robert Langreth and BloombergJuly 2, 2024
Bernie Sanders
Politics
‘Outrageous’: Bernie Sanders has Ozempic demands after study says it costs just $5 per month to manufacture
By Madison Muller, Robert Langreth and BloombergMarch 28, 2024
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
Health
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
By Madison Muller, Robert Langreth and BloombergMarch 28, 2024
Moderna’s updated COVID vaccine helps fight against a new strain, study shows, and may be approved for use as soon as Friday
Health
Moderna’s updated COVID vaccine helps fight against a new strain, study shows, and may be approved for use as soon as Friday
By Robert Langreth and BloombergSeptember 6, 2023
Moderna COVID-19 vaccine
Health
Moderna’s Omicron vaccine produces antibodies against new variants, new trial shows
By Robert Langreth and BloombergJune 22, 2022
Moderna vaccine
Health
Moderna says its Omicron-specific vaccine boosts antibodies in new trial
By Robert Langreth and BloombergJune 8, 2022
Prescription Pills
Health
New prescription drug prices soared to $180,000 a year on 20% annual inflation in 2021, study finds
By Robert Langreth and BloombergJune 7, 2022
Young girl gets Pfizer COVID vaccine
Health
Pfizer says a third vaccine dose boosts antibodies against Omicron in kids 5 to 11
By Robert Langreth and BloombergApril 14, 2022
Almost all teens needing ICU care for COVID are unvaccinated
Health
Almost all teens needing ICU care for COVID are unvaccinated
By Robert Langreth and BloombergJanuary 12, 2022
COVID-19 pill
Health
FDA set to authorize Pfizer and Merck COVID pills this week
By Josh Wingrove, Jennifer Jacobs, Robert Langreth and BloombergDecember 21, 2021
Pfizer: COVID vaccine is 91% effective in kids ages 5 to 11
Health
Pfizer: COVID vaccine is 91% effective in kids ages 5 to 11
By Robert Langreth and BloombergOctober 22, 2021
Pfizer submits request to authorize COVID vaccine for kids to FDA
Health
Pfizer submits request to authorize COVID vaccine for kids to FDA
By Robert Langreth, Catherine Larkin and BloombergOctober 7, 2021
Two recent studies help explain breakthrough infections in those with two COVID-19 vaccine doses
Health
Two recent studies help explain breakthrough infections in those with two COVID-19 vaccine doses
By Alisa Odenheimer, Robert Langreth and BloombergOctober 7, 2021
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Success
Elon Musk on MacKenzie Scott giving away $26 billion of her fortune: 'Sadly,' it makes the world a worse placeplaceholder alt text
By Sydney LakeJune 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.